Cover Image

An accelerated hypofractionated radiotherapy regimen in patients after organ-sparing surgery for stages I-IIA breast cancer

Objective: to assess the results of accelerated hypofractionated radiotherapy and to comparatively analyze it with the standard radiotherapy in patients with stages I-IIA breast cancer (BC) after organ-sparing surgery.Materials and methods. A total of 203 patients with stages I-IIA BC underwent radi...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. A. Gladilina (Author), L. Ya. Klepper (Author), Yu. V. Efimkina (Author), I. V. Vysotskaya (Author), A. V. Petrovskiy (Author), O. V. Kozlov (Author), M. V. Chernykh (Author), E. Yu. Voronchikhina (Author), E. S. Makarov (Author), A. V. Ivanova (Author)
Format:	Book
Published:	ABV-press, 2016-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hypofractionated radiotherapy regimens after organ-sparing surgery for stages I-IIa breast cancer
by: Yu. V. Efimkina, et al.
Published: (2014)

Use of hypofractionated radiotherapy regimens after organ-sparing surgery for Stages I-IIA breast cancers
by: Yu. V. Efimkina, et al.
Published: (2014)

Radiotherapy following organ-sparing surgery for breast cancer
by: I. A. Gladilina, et al.
Published: (2014)

Comparative analysis of the long-term results of treatment in patients with Stages I-IIa breast cancer in relation to major prognostic factors
by: Yu. V. Efimkina, et al.
Published: (2014)

Use of a synthesized mathematical model to describe the probability of curing early-stage breast cancer
by: L. Ya. Klepper, et al.
Published: (2015)

Economic evaluation of postoperative hypofractionated radiation therapy in patients with breast cancer
by: G. V. Afonin, et al.
Published: (2018)

Utility of radiotherapy for the management of local tumor progression in patients with early breast cancer
by: I. A. Gladilina, et al.
Published: (2023)

Comparative analysis of parasternal lymph collector exposures in the organ-sparing treatment of patients with operable breast cancer
by: V. A. Uimanov, et al.
Published: (2014)

Dose-Response of TLD-100 in the Dose Range Useful for Hypofractionated Radiotherapy
by: Raffaele Liuzzi, et al.
Published: (2020)

Incidence of acute radiodermatitis in women with breast cancer undergoing hypofractionated radiotherapy
by: Laura Beatriz Sousa de Jesus Martelletti, et al.
Published: (2021)

A comparative study of hypofractionated and conventional radiotherapy in postmastectomy breast cancer patients
by: Kartick Rastogi, et al.
Published: (2018)

Optimization of indications for parasternal radiotherapy in patients with breast cancer
by: A. A. Zaytceva, et al.
Published: (2014)

Hypofractionated Postmastectomy Radiotherapy (HF-PMRT): What did We Learn from COVID-19 Era?
by: Viola Salvestrini, et al.
Published: (2023)

LONG-TERM PROGNOSIS IN PATIENTS WITH A LOCAL BREAST CANCER RELAPSE AFTER ORGAN-SAVING TREATMENT
by: V. A. Uimanov, et al.
Published: (2014)

Organ-sparing treatment for primarily disseminated breast cancer with metachronous bilateral involvement
by: Yu. A. Ragulin, et al.
Published: (2016)

MODERATE HYPOFRACTIONATION RADIATION THERAPY IN ESOPHAGEAL CANCER
by: Mahwish Akhter, et al.
Published: (2019)

Outcomes of combination therapy for stage IIA-IIIB cervical cancer
by: D. K. Reyes Santiago, et al.
Published: (2019)

Place of organ-sparing surgery in the treatment of early breast cancer in elderly and senile patients
by: V. V. Rodionov, et al.
Published: (2014)

THE SENTINEL LYMPH NODE CONCEPT IN IA2-IIA2 STAGES CERVICAL CANCER: CLINICAL PERSPECTIVES
by: A. I. Berishvili, et al.
Published: (2018)

Advantages, disadvantages and optimization of organ-sparing methods for uterine fibroids treatment
by: A. L. Tikhomirov, et al.
Published: (2020)

A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study
by: Spagnuolo V, et al.
Published: (2019)

Linear accelerator-based radiosurgery and hypofractionated stereotactic radiotherapy for brain metastasis secondary to gynecologic malignancies: A single institution series examining outcomes of a rare entity
by: Michael J. Gigliotti, et al.
Published: (2018)

Lesions of the breast with uncertain malignant potential
by: I. V. Vуsotskaya, et al.
Published: (2021)

Cost-effectiveness of hypofractionated versus conventional fractionated radiotherapy for the treatment of men with early glottic cancer: a study in the Brazilian public and private health system
by: Marina Lourenção, et al.
Published: (2023)

Results of sparing omentum resection in children with apendicular peritonitis
by: M. Melnychenko, et al.
Published: (2018)

Results of sparing omentum resection in children with apendicular peritonitis
by: M. Melnychenko, et al.
Published: (2018)

Steroid sparing regimens for management of oral immune-mediated diseases
by: Arti Agrawal, et al.
Published: (2014)

Prolonged regimens for combined oral contraceptives
by: I V Kuznetsova
Published: (2017)

Preliminary results of hypofractionated radiotherapy in breast cancer in Chandigarh, India: single-centre, non-inferiority, open-label, randomised, phase 3 trialResearch in context
by: Budhi Singh Yadav, et al.
Published: (2024)

Molecular effects of Mastodynon: realities and prospects for cancer prevention
by: I. V. Vysotskaya, et al.
Published: (2022)

Effect of ethylmethylhydroxypyridine succinate on the functional activity of the transporter P-glycoprotein in the blood-brain barrier of rats under normal conditions and under hypoxic hypoxia
by: P. Yu. Mylnikov, et al.
Published: (2022)

New opportunities to reduce blood loss when performing sparing-surgery on the uterus
by: S P Sinichikhin, et al.
Published: (2014)

Moderately hypofractionated radiation therapy for breast cancer: A Brazilian cohort study
by: Gabriela S.M. de Siqueira, et al.
Published: (2022)

Modern possibilities for the correction of menopausal symptoms in patients with breast cancer, depending on the molecular biological characteristics of the tumor (literature review)
by: I. V. Vysotskaya, et al.
Published: (2023)

American Society of Clinical Oncology recommendations of Bisphosphonates administration and bone health issues in women with breast cancer. Part 1. Recommendations on Bisphosphonates use in the treatment of patients with breast cancer.
by: I. V. Vysotskaya
Published: (2014)

American society of clinical oncology update on the role of bisphosphonates and bone health issues in women with breast cancer Part II. Bisphosphonates in the adjuvant therapy of breast cancer
by: I. V. Vysotskaya
Published: (2014)

CURRENT POTENTIALITIES OF THERAPY FOR FIBROCYSTIC DISEASE
by: I. V. Vysotskaya
Published: (2014)

Possibilities to improve breast cancer screening
by: I. V. Vysotskaya
Published: (2014)

Current feasibility of endocrine therapy for breast cancer
by: I. V. Vysotskaya
Published: (2014)

Adjuvant therapy for early breast cancer
by: I. V. Vysotskaya
Published: (2014)